Talbot JN - Search Results

1

Early 18F-FDG PET for prediction of prognosis in patients with diffuse large B-cell lymphoma: SUV-based assessment versus visual analysis.

Lin C, Itti E, Haioun C, Petegnief Y, Luciani A, Dupuis J, Paone G, Talbot JN, Rahmouni A, Meignan M. Lin C, et al. Among authors: talbot jn. J Nucl Med. 2007 Oct;48(10):1626-32. doi: 10.2967/jnumed.107.042093. Epub 2007 Sep 14. J Nucl Med. 2007. PMID: 17873129 Free article.

2

Evaluation of FDG uptake by renal malignancies (primary tumor or metastases) using a coincidence detection gamma camera.

Montravers F, Grahek D, Kerrou K, Younsi N, Doublet JD, Gattegno B, Rossert J, Costa de Beauregard MA, Thibault P, Talbot JN. Montravers F, et al. Among authors: talbot jn. J Nucl Med. 2000 Jan;41(1):78-84. J Nucl Med. 2000. PMID: 10647608 Free article.

3

Myocardial viability assessment with FDG imaging: comparison of PET, SPECT, and gamma-camera coincidence detection.

Kerrou K, Toussaint JF, Froissart M, Talbot JN. Kerrou K, et al. Among authors: talbot jn. J Nucl Med. 2000 Dec;41(12):2099. J Nucl Med. 2000. PMID: 11138698 Free article. No abstract available.

4

[18F]-FDG positron imaging in clinical management of lymphoma patients.

Talbot JN, Haioun C, Rain JD, Meignan M, Wioland M, Misset JL, Grahek D, Kerrou K, Montravers F. Talbot JN, et al. Crit Rev Oncol Hematol. 2001 Jun;38(3):193-221. doi: 10.1016/s1040-8428(01)00127-5. Crit Rev Oncol Hematol. 2001. PMID: 11369254 Review.

5

Advanced radionuclide detection techniques for in vitro and in vivo animal imaging.

Petegnief Y, Aubineau-Laniece I, Kerrou K, Jourdain JR, Talbot JN. Petegnief Y, et al. Among authors: talbot jn. Cell Mol Biol (Noisy-le-grand). 2001 May;47(3):443-51. Cell Mol Biol (Noisy-le-grand). 2001. PMID: 11441951 Review.

6

[18F]-FDG uptake in soft tissue dermatome prior to herpes zoster eruption: an unusual pitfall.

Kerrou K, Montravers F, Grahek D, Younsi N, Perniceni T, Godeberge P, Canuel C, De Gramont A, Talbot JN. Kerrou K, et al. Among authors: talbot jn. Ann Nucl Med. 2001 Oct;15(5):455-8. doi: 10.1007/BF02988353. Ann Nucl Med. 2001. PMID: 11758954

7

[(18F)-fluoro-2-deoxyglucose PET in imaging of gynecologic cancers].

Talbot JN, Grahek D, Kerrou K, Younsi N, de Beco V, Colombet-Lamau C, Petegnief Y, Cailleux N, Montravers F. Talbot JN, et al. Gynecol Obstet Fertil. 2001 Nov;29(11):775-98. doi: 10.1016/s1297-9589(01)00197-7. Gynecol Obstet Fertil. 2001. PMID: 11770272 Review. French.

8

[Positron emission tomography (PET) with [18F]-FDG in bronchopulmonary cancer and its impact on medical decision at the time of diagnosis, staging, or recurrence evaluation].

Grahek D, Montravers F, Mayaud C, Regnard JF, Kerrou K, Younsi N, Talbot JN. Grahek D, et al. Among authors: talbot jn. Rev Pneumol Clin. 2001 Dec;57(6):393-403. Rev Pneumol Clin. 2001. PMID: 11924148 Review. French.

9

[(18)F]FDG in childhood lymphoma: clinical utility and impact on management.

Montravers F, McNamara D, Landman-Parker J, Grahek D, Kerrou K, Younsi N, Wioland M, Leverger G, Talbot JN. Montravers F, et al. Among authors: talbot jn. Eur J Nucl Med Mol Imaging. 2002 Sep;29(9):1155-65. doi: 10.1007/s00259-002-0861-y. Epub 2002 Jun 25. Eur J Nucl Med Mol Imaging. 2002. PMID: 12192560

10

[Value of [18F]-fluorodeoxyglucose (FDG) positron emission tomography in digestive cancerology].

Montravers F, Kerrou K, Grahek D, Zerbib E, Mabille L, Younsi N, Petegnief Y, De Beco V, Colombet-Lamau C, Talbot JN. Montravers F, et al. Among authors: talbot jn. Presse Med. 2002 Oct 12;31(33):1560-8. Presse Med. 2002. PMID: 12422485 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

221 results

Search Page

Filters